Coromandel International
Coromandel International Limited manufactures and trades in farm inputs in India. The last earnings update was 89 days ago. More info.
Add to Portfolio Compare Print
COROMANDEL Share Price and Events
7 Day Returns
1 Year Returns
COROMANDEL Shareholder Return
| 7 Day | 30 Day | 90 Day | 1 Year | 3 Year | 5 Year | |
|---|---|---|---|---|---|---|
| Coromandel International (COROMANDEL) | 1.2% | -6.4% | -2.7% | -17% | 100.1% | 99.4% |
| IN Chemicals | 0.1% | 2% | 3.6% | -0.9% | 67.8% | 198% |
| IN Market | 0.8% | 2.1% | 5.8% | -0.7% | 41.2% | 72.5% |
1 Year Return vs Industry and Market
- COROMANDEL underperformed the Chemicals industry which returned -0.9% over the past year.
- COROMANDEL underperformed the Market in India which returned -0.7% over the past year.
Value
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current
share
price of
Coromandel International
to its discounted cash flow analysis.value.The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Below are the data sources, inputs and calculation used to determine the intrinsic value for Coromandel International.
| Data Point | Source | Value |
|---|---|---|
| Valuation Model | 2 Stage Free Cash Flow to Equity | |
| Levered Free Cash Flow | Average of 10 Analyst Estimates (S&P Global) | See below |
| Discount Rate (Cost of Equity) | See below | 16.3% |
| Perpetual Growth Rate | 10-Year IN Government Bond Rate | 7.6% |
An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.
| Data Point | Calculation/ Source | Result |
|---|---|---|
| Risk-Free Rate | 10-Year IN Govt Bond Rate | 7.6% |
| Equity Risk Premium | S&P Global | 8.6% |
| Chemicals Unlevered Beta | Simply Wall St/ S&P Global | 0.93 |
| Re-levered Beta | = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.93 (1 + (1- 35%) (16.57%)) |
1.02 |
| Levered Beta | Levered Beta limited to 0.8 to 2.0 (practical range for a stable firm) |
1.02 |
| Discount Rate/ Cost of Equity |
= Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 7.55% + (1.02 * 8.6%) |
16.33% |
Discounted Cash Flow Calculation for NSEI:COROMANDEL using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for Coromandel International is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.
| Levered FCF (INR, Millions) | Source |
Present Value Discounted (@ 16.33%) |
|
|---|---|---|---|
| 2019 | 724.50 | Analyst x2 | 622.82 |
| 2020 | 8,058.00 | Analyst x1 | 5,954.92 |
| 2021 | 6,955.67 | Analyst x3 | 4,418.87 |
| 2022 | 6,853.32 | Est @ -1.47% | 3,742.81 |
| 2023 | 6,937.96 | Est @ 1.23% | 3,257.26 |
| 2024 | 7,155.08 | Est @ 3.13% | 2,887.75 |
| 2025 | 7,473.88 | Est @ 4.46% | 2,593.08 |
| 2026 | 7,876.27 | Est @ 5.38% | 2,349.17 |
| 2027 | 8,351.51 | Est @ 6.03% | 2,141.33 |
| 2028 | 8,893.41 | Est @ 6.49% | 1,960.25 |
| Present value of next 10 years cash flows | ₹29,928.27 | ||
| Calculation | Result | |
|---|---|---|
| Terminal Value |
= FCF2028
× (1 + g) ÷ (Discount Rate – g)
= ₹8,893.41 × (1 + 7.55%) ÷ (16.33% – 7.55%) |
₹108,992.39 |
| Present Value of Terminal Value |
= Terminal Value ÷ (1 + r)10
= ₹108,992.39 ÷ (1 + 16.33%)10 |
₹24,023.64 |
| Calculation | Result | |
|---|---|---|
| Total Equity Value |
= Present value of next 10 years cash flows +
Terminal Value
= ₹29,928.27 + ₹24,023.64 |
₹53,951.92 |
| Equity Value per Share (INR) |
= Total value / Shares Outstanding
= ₹53,951.92 / 292.53 |
₹184.43 |
| Calculation | Result | |
|---|---|---|
| Value per share (INR) | From above. | ₹184.43 |
| Current discount | Discount to share price of
₹439.85
= -1 x (₹439.85 - ₹184.43) / ₹184.43 |
-138.5% |
Learn more about our DCF calculations in Simply Wall St’s analysis model .
- The current share price of Coromandel International is above its future cash flow value.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.The amount the stock market is willing to pay for Coromandel International's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are
Coromandel International's earnings available for a low price, and how does
this compare to other companies in the same industry?
| Data Point | Source | Value |
|---|---|---|
| Earnings Per Share * | Company Filings (2018-12-31) in INR | ₹22.98 |
| NSEI:COROMANDEL Share Price ** | NSEI (2019-04-18) in INR | ₹439.85 |
| India Chemicals Industry PE Ratio | Median Figure of 232 Publicly-Listed Chemicals Companies | 15.5x |
| India Market PE Ratio | Median Figure of 2,738 Publicly-Listed Companies | 16.33x |
* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.
** Primary Listing of Coromandel International.
| Calculation | Outcome | |
|---|---|---|
| PE Ratio | = NSEI:COROMANDEL Share Price ÷ EPS (both in INR) = 439.85 ÷ 22.98 |
19.14x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Coromandel International is overvalued based on earnings compared to the IN Chemicals industry average.
- Coromandel International is overvalued based on earnings compared to the India market.
Price based on expected Growth
Does
Coromandel International's expected growth come at a high price?
| Data Point | Source | Value |
|---|---|---|
| PE Ratio | See PE Ratio Section | 19.14x |
| Net Income Annual Growth Rate | See Future Growth Section. Line of Best Fit* through Consensus Estimate Earnings of 10 Analysts |
14.7%per year |
| India Chemicals Industry PEG Ratio | Median Figure of 60 Publicly-Listed Chemicals Companies | 1.28x |
| India Market PEG Ratio | Median Figure of 584 Publicly-Listed Companies | 1.32x |
*Line of best fit is calculated by linear regression .
| Calculation | Outcome | |
|---|---|---|
| PEG Ratio | = PE Ratio ÷ Net Income Annual Growth Rate = 19.14x ÷ 14.7% |
1.3x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Coromandel International is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on
Coromandel International's
assets?
| Data Point | Source | Value |
|---|---|---|
| Book Value per Share | Company Filings (2018-12-31) in INR | ₹110.35 |
| NSEI:COROMANDEL Share Price * | NSEI (2019-04-18) in INR | ₹439.85 |
| India Chemicals Industry PB Ratio | Median Figure of 267 Publicly-Listed Chemicals Companies | 1.51x |
| India Market PB Ratio | Median Figure of 3,628 Publicly-Listed Companies | 1.11x |
| Calculation | Outcome | |
|---|---|---|
| PB Ratio | = NSEI:COROMANDEL Share Price ÷ Book Value per Share (both in INR) = 439.85 ÷ 110.35 |
3.99x |
* Primary Listing of Coromandel International.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Coromandel International is overvalued based on assets compared to the IN Chemicals industry average.
Value checks
We assess Coromandel International's value by looking at:- Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
- Is the PE ratio less than the market average, and/ or less than the Chemicals industry average (and greater than 0)? (2 checks)
- Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
- Is the PB ratio less than the Chemicals industry average (and greater than 0)? (1 check) Coromandel International has a total score of 0/6, see the detailed checks below.
Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.
Full details on the Value part of the Simply Wall St company analysis model.
Future Performance
The future performance of a company is measured in the same way as past
performance, by looking at estimated
growth
and how much profit it is expected to make.Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Earnings growth vs Low Risk Savings
- Coromandel International's earnings growth is expected to exceed the low risk savings rate of 7.6%.
Growth vs Market Checks
- Coromandel International's earnings growth is positive but not above the India market average.
- Coromandel International's revenue growth is positive but not above the India market average.
Annual Growth Rates Comparison
| Data Point | Source | Value (per year) |
|---|---|---|
| NSEI:COROMANDEL Future Earnings Growth Rate | Line of Best Fit* through Consensus Estimate Earnings of 10 Analysts | 14.7% |
| NSEI:COROMANDEL Future Revenue Growth Rate | Line of Best Fit* through Consensus Estimate Revenue of 10 Analysts | 7.6% |
| India Chemicals Industry Earnings Growth Rate | Market Cap Weighted Average | 18.4% |
| India Chemicals Industry Revenue Growth Rate | Market Cap Weighted Average | 14.6% |
| India Market Earnings Growth Rate | Market Cap Weighted Average | 18.5% |
| India Market Revenue Growth Rate | Market Cap Weighted Average | 11.7% |
*Line of best fit is calculated by linear regression .
Industry and Market average data is calculated daily.
Learn more about our growth rate calculations in Simply Wall St’s analysis model.
Analysts growth expectations
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (3 months ago) | See Below |
| Future Estimates | Average of up to 10 Analyst Estimates (S&P Global) | See Below |
| Date (Data in INR Millions) | Revenue | Cash Flow | Net Income * | Avg. No. Analysts |
|---|---|---|---|---|
| 2023-03-31 | ||||
| 2021-03-31 | 154,416 | 7,501 | 9,694 | 9 |
| 2020-03-31 | 145,094 | 8,536 | 8,578 | 10 |
| 2019-03-31 | 133,263 | 5,427 | 7,369 | 10 |
| Date (Data in INR Millions) | Revenue | Cash Flow | Net Income * |
|---|---|---|---|
| 2018-12-31 | 128,618 | 6,721 | |
| 2018-09-30 | 125,473 | 6,982 | |
| 2018-06-30 | 112,143 | 6,812 | |
| 2018-03-31 | 109,467 | 2,556 | 6,636 |
| 2017-12-31 | 108,344 | 7,344 | |
| 2017-09-30 | 103,747 | 6,740 | |
| 2017-06-30 | 102,471 | 5,449 | |
| 2017-03-31 | 100,308 | 9,152 | 4,770 |
| 2016-12-31 | 108,219 | 4,286 | |
| 2016-09-30 | 113,339 | 3,976 | |
| 2016-06-30 | 113,656 | 3,537 | |
| 2016-03-31 | 114,814 | 184 | 3,574 |
*GAAP earnings excluding extraordinary items.
Past and Future Earnings per Share
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (3 months ago) | See Below |
| Future Estimates | Average of up to 10 Analyst Estimates (S&P Global) | See Below |
All data from Coromandel International Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in INR Millions) | EPS * | EPS High Estimate | EPS Low Estimate | Avg. No. Analysts |
|---|---|---|---|---|
| 2023-03-31 | 39.80 | 39.80 | 39.80 | 1.00 |
| 2021-03-31 | 33.20 | 35.50 | 31.00 | 6.00 |
| 2020-03-31 | 29.37 | 31.10 | 27.92 | 7.00 |
| 2019-03-31 | 25.40 | 26.50 | 24.70 | 8.00 |
| Date (Data in INR Millions) | EPS * |
|---|---|
| 2018-12-31 | 22.98 |
| 2018-09-30 | 23.89 |
| 2018-06-30 | 23.32 |
| 2018-03-31 | 22.72 |
| 2017-12-31 | 25.16 |
| 2017-09-30 | 23.10 |
| 2017-06-30 | 18.64 |
| 2017-03-31 | 16.36 |
| 2016-12-31 | 14.70 |
| 2016-09-30 | 13.64 |
| 2016-06-30 | 12.15 |
| 2016-03-31 | 12.27 |
*GAAP earnings excluding extraordinary items.
Performance in 3 years
In the same way as past performance we look at the future estimated return
(profit) compared to the available
funds. We do this looking forward 3 years.
- Coromandel International is expected to efficiently use shareholders’ funds in the future (Return on Equity greater than 20%).
Future performance checks
We assess Coromandel International's future performance by looking at:- Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
- Is the annual earnings growth rate expected to beat the average growth rate in earnings of the India market? (1 check)
- Is the annual revenue growth rate expected to beat the average growth rate in revenue of the India market? (1 check)
- Is the annual earnings growth rate expected to be above 20%? (1 check)
- Is the annual revenue growth rate expected to be above 20%? (1 check)
- Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Coromandel International has a total score of 2/6, see the detailed checks below.
Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.
Full details on the Future part of the Simply Wall St company analysis model.
Past Performance
How has Coromandel International performed over the past 5 years?
The past performance of a company can be measured by how much
growth
it has experienced and how much profit it makes relative to the funds and assets
it has available.
Past earnings growth
Past Earnings growth analysis
- Coromandel International's year on year earnings growth rate has been positive over the past 5 years.
- Coromandel International's 1-year earnings growth is negative, it can't be compared to the 5-year average.
- Coromandel International's 1-year earnings growth is negative, it can't be compared to the IN Chemicals industry average.
Earnings and Revenue History
All data from Coromandel International Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in INR Millions) | Revenue | Net Income * | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 2018-12-31 | 128,618.40 | 6,720.50 | 5,251.80 | |
| 2018-09-30 | 125,472.70 | 6,982.00 | 4,992.10 | |
| 2018-06-30 | 112,142.50 | 6,811.80 | 4,477.00 | |
| 2018-03-31 | 109,467.10 | 6,636.20 | 4,372.00 | |
| 2017-12-31 | 108,343.90 | 7,343.60 | 5,184.30 | |
| 2017-09-30 | 103,747.00 | 6,740.40 | 4,642.00 | |
| 2017-06-30 | 102,470.50 | 5,449.00 | 4,135.40 | |
| 2017-03-31 | 100,307.50 | 4,769.60 | 3,500.70 | |
| 2016-12-31 | 108,218.90 | 4,286.30 | 3,747.30 | |
| 2016-09-30 | 113,338.80 | 3,976.10 | 3,541.20 | |
| 2016-06-30 | 113,656.30 | 3,537.30 | 3,385.90 | |
| 2016-03-31 | 114,814.20 | 3,574.40 | 3,251.60 | |
| 2015-12-31 | 114,974.70 | 3,369.60 | 11,110.10 | |
| 2015-09-30 | 117,041.00 | 3,772.90 | 10,947.40 | |
| 2015-06-30 | 116,057.20 | 3,837.10 | 10,695.60 | |
| 2015-03-31 | 113,052.60 | 4,017.90 | 3,053.80 | |
| 2014-12-31 | 104,874.60 | 4,135.10 | 9,531.60 | |
| 2014-09-30 | 102,815.60 | 3,870.30 | 9,632.60 | |
| 2014-06-30 | 100,309.10 | 3,672.20 | 9,411.70 | |
| 2014-03-31 | 100,478.70 | 3,560.90 | 9,213.70 | |
| 2013-12-31 | 99,453.10 | 2,873.80 | 8,988.30 | |
| 2013-09-30 | 96,136.00 | 2,615.60 | 7,829.50 | |
| 2013-06-30 | 90,733.90 | 3,383.60 | 7,741.00 | |
| 2013-03-31 | 90,302.50 | 4,319.90 | 7,672.70 | |
| 2012-12-31 | 96,342.30 | 4,872.10 | 7,192.10 | |
| 2012-09-30 | 97,718.00 | 5,494.50 | 7,089.00 | |
| 2012-06-30 | 98,899.80 | 5,949.50 | 6,977.60 |
*GAAP earnings excluding extraordinary items.
Performance last year
We want to ensure a company is making the most of what it has available. This is
done by comparing the return (profit) to a company's available
funds,
assets
and
capital.
- Coromandel International has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).
- Coromandel International used its assets more efficiently than the IN Chemicals industry average last year based on Return on Assets.
- Coromandel International has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
Past performance checks
We assess Coromandel International's performance over the past 5 years by checking for:- Has earnings increased in past 5 years? (1 check)
- Has the earnings growth in the last year exceeded that of the Chemicals industry? (1 check)
- Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
- Is the Return on Equity (ROE) higher than 20%? (1 check)
- Is the Return on Assets (ROA) above industry average? (1 check)
- Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
Coromandel International has a total score of 4/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Full details on the Past part of the Simply Wall St company analysis model.
Health
How is Coromandel International's financial health and their level of debt?
A company's financial position is much like your own financial position,
it includes everything you own
(assets)
and owe
(liabilities).The boxes below represent the relative size of what makes up Coromandel International's finances.
The net worth of a company is the difference between its assets and liabilities.
- Coromandel International is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Coromandel International's cash and other short term assets cover its long term commitments.
Balance sheet
Assets
Liabilities and shares
- High level of physical assets or inventory.
- Debt is covered by short term assets, assets are 3.8x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t
bad,
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
All data from Coromandel International Company Filings, last reported 3 months ago.
| Date (Data in INR Millions) | Total Equity | Total Debt | Cash & Short Term Investments |
|---|---|---|---|
| 2018-12-31 | 32,272.90 | 21,316.70 | 2,339.60 |
| 2018-09-30 | 32,272.90 | 21,316.70 | 2,339.60 |
| 2018-06-30 | 31,258.60 | 27,284.40 | 4,420.40 |
| 2018-03-31 | 31,258.60 | 27,284.40 | 4,420.40 |
| 2017-12-31 | 31,149.20 | 16,252.10 | 2,860.10 |
| 2017-09-30 | 31,149.20 | 16,252.10 | 2,860.10 |
| 2017-06-30 | 28,907.70 | 22,283.80 | 1,468.40 |
| 2017-03-31 | 28,907.70 | 22,283.80 | 1,468.40 |
| 2016-12-31 | 27,123.90 | 26,159.80 | 3,156.10 |
| 2016-09-30 | 27,123.90 | 26,159.80 | 3,156.10 |
| 2016-06-30 | 24,248.90 | 22,663.50 | 2,031.50 |
| 2016-03-31 | 26,339.60 | 26,767.00 | 2,171.50 |
| 2015-12-31 | 23,910.10 | 25,498.60 | 2,449.50 |
| 2015-09-30 | 23,910.10 | 25,498.60 | 2,449.50 |
| 2015-06-30 | 22,020.10 | 22,950.70 | 3,177.80 |
| 2015-03-31 | 22,020.10 | 22,950.70 | 3,177.80 |
| 2014-12-31 | 25,224.60 | 21,926.20 | 3,108.80 |
| 2014-09-30 | 25,224.60 | 21,926.20 | 3,108.80 |
| 2014-06-30 | 23,066.00 | 18,513.80 | 4,723.50 |
| 2014-03-31 | 23,066.00 | 18,513.80 | 4,723.50 |
| 2013-12-31 | 24,548.70 | 23,030.50 | 5,255.00 |
| 2013-09-30 | 24,548.70 | 23,030.50 | 5,255.00 |
| 2013-06-30 | 23,028.50 | 29,458.30 | 5,347.80 |
| 2013-03-31 | 23,028.50 | 29,458.30 | 5,347.80 |
| 2012-12-31 | 22,755.60 | 25,623.00 | 5,205.60 |
| 2012-09-30 | 22,755.60 | 25,623.00 | 5,205.60 |
| 2012-06-30 | 24,161.10 | 29,434.10 | 9,847.60 |
- Coromandel International's level of debt (66.1%) compared to net worth is high (greater than 40%).
- The level of debt compared to net worth has been reduced over the past 5 years (93.7% vs 66.1% today).
- Debt is not well covered by operating cash flow (12%, less than 20% of total debt).
- Interest payments on debt are well covered by earnings (EBIT is 7.6x coverage).
Financial health checks
We assess Coromandel International's financial health by checking for:- Are short term assets greater than short term liabilities? (1 check)
- Are short term assets greater than long term liabilities? (1 check)
- Has the debt to equity ratio increased in the past 5 years? (1 check)
- Is the debt to equity ratio over 40%? (1 check)
- Is the debt covered by operating cash flow? (1 check)
- Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check) Coromandel International has a total score of 4/6, see the detailed checks below.
- Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
- Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
Full details on the Health part of the Simply Wall St company analysis model.
Dividends
What is Coromandel International's current dividend yield, its reliability and sustainability?
Dividends are regular cash payments to you from the company, similar to a
bank paying you interest on a savings account.
Annual Dividend Income
If you bought
₹2,000 of
Coromandel International
shares you are expected to receive
₹30
in your first year as a dividend.
Dividend Amount
- Coromandel International's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.5%).
- Coromandel International's dividend is below the markets top 25% of dividend payers in India (1.92%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not
wildly increasing/decreasing each year. This graph shows you the historical rate
to count toward your assessment of the stock.We also check to see if the dividend has increased in the past 10 years.
| Data Point | Source | Value |
|---|---|---|
| Past Annualized Dividend Yield | S&P Global Market Data | See Below |
| Past Dividends per Share | Company Filings/ Annualized Dividend Payments | See Below |
| Future Dividends per Share Estimates | Average of up to 10 Analyst Estimates (S&P Global) | See Below |
| India Chemicals Industry Average Dividend Yield | Market Cap Weighted Average of 164 Stocks | 0.9% |
| India Market Average Dividend Yield | Market Cap Weighted Average of 1400 Stocks | 1.3% |
| India Minimum Threshold Dividend Yield | 10th Percentile | 0.3% |
| India Bottom 25% Dividend Yield | 25th Percentile | 0.5% |
| India Top 25% Dividend Yield | 75th Percentile | 1.9% |
Industry and Market average data is calculated daily.
Note all dividend per share amounts are annualized and not quarterly or other period.
| Date (Data in ₹) | Dividend per Share (annual) | Avg. No. Analysts |
|---|---|---|
| 2023-03-31 | ||
| 2021-03-31 | 9.84 | 6.00 |
| 2020-03-31 | 8.70 | 7.00 |
| 2019-03-31 | 7.41 | 6.00 |
| Date (Data in ₹) | Dividend per share (annual) | Avg. Yield (%) |
|---|---|---|
| 2019-01-21 | 6.500 | 1.424 |
| 2018-04-24 | 7.000 | 1.663 |
| 2018-03-16 | 6.000 | 1.144 |
| 2017-04-28 | 5.000 | 1.070 |
| 2016-06-30 | 4.000 | 1.418 |
| 2016-04-27 | 4.000 | 1.702 |
| 2016-01-22 | 0.000 | 0.000 |
| 2015-07-02 | 5.000 | 2.597 |
| 2015-04-30 | 5.000 | 2.072 |
| 2015-01-23 | 4.000 | 1.468 |
| 2014-11-03 | 4.000 | 1.287 |
| 2014-08-25 | 4.500 | 1.505 |
| 2013-06-26 | 4.500 | 2.056 |
| 2013-04-23 | 4.500 | 2.381 |
| 2012-07-24 | 7.000 | 2.868 |
| 2012-01-23 | 7.000 | 2.588 |
| 2011-04-21 | 7.000 | 2.259 |
| 2010-08-30 | 5.000 | 1.721 |
| 2009-04-24 | 5.000 | 4.059 |
| 2009-04-21 | 5.000 | 8.429 |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
- Dividends per share have increased over the past 10 years.
Current Payout to shareholders
What portion of
Coromandel International's earnings are
paid
to the shareholders as a dividend.
- Dividends paid are well covered by earnings (3.5x coverage).
- Dividends after 3 years are expected to be well covered by earnings (3.7x coverage).
Income/ dividend checks
We assess Coromandel International's dividend by checking for:- Firstly is the company paying a notable dividend (greater than 0.3%) - if not then the rest of the checks are ignored.
- Is current dividend yield above the bottom 25% of dividend payers? (1 check)
- Is current dividend yield above the top 25% of dividend payers? (1 check)
- Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
- If they have paid a dividend for 10 years has it increased in this time? (1 check)
- How sustainable is the dividend, can Coromandel International afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks) Coromandel International has a total score of 4/6, see the detailed checks below.
Full details on the Dividends part of the Simply Wall St company analysis model.
Management
CEO
| COMPENSATION | ₹40,571,711 |
| AGE | 55 |
| TENURE AS CEO | 3.5 years |
CEO Bio
Mr. Sameer Goel has been a Managing Director and Director at Coromandel International Limited since October 1, 2015. Mr. Goel started his career in 1987 with GlaxoSmithKline Consumer Healthcare (GSK) as Area Sales Manager. In his career with GSK, spanning more than 25 years, he has held various roles in India, UK, UAE, Nigeria and South Africa and was Vice President for Africa when he moved from GSK. Prior to joining Coromandel, he was with Cipla Limited as Country Head - India. He has extensive experience in managing businesses, driving sales across multiple geographies and building B2C businesses. Mr. Sameer Goel had served on the Advisory Board of Lagos Business School; he was a Member of Africa Economist Forum and a Member of the Commercial Directors Forum in India. He holds a Post Graduate Diploma in Management from Indian Institute of Management, Ahmedabad. He also holds a Bachelor’s degree in Economics from St. Stephens College, New Delhi.
CEO Compensation
- Sameer's compensation has been consistent with company performance over the past year.
- Sameer's remuneration is about average for companies of similar size in India.
Management Team Tenure
Average tenure and age of the Coromandel International management team in years:
- The tenure for the Coromandel International management team is about average.
Management Team
Murugappan Murugappan
Executive Chairman
₹3M
63
Sameer Goel
MD & Executive Director
₹41M
55
3.5 yrs
Jayashree Satagopan
CFO & Executive VP
₹15M
50
1.5 yrs
P. Varadarajan
Senior VP of Legal
₹7M
5.8 yrs
B. Rao
Executive VP & Head of Human Resources
57
3.5 yrs
G. Veerabhadram
President of Crop Protection
60
Seshadri Govindarajan
Executive VP & Head of Commercial
55
Arun George
Head of Business - SSP & Executive VP
51
S. Sankarasubramanian
President & Head of Fertilisers
₹14M
49
Ripu Singh
Executive VP & Head of Retail
56
Board of Directors Tenure
Average tenure and age of the Coromandel International board of directors in years:
- The tenure for the Coromandel International board of directors is about average.
Board of Directors
Sameer Goel
MD & Executive Director
₹41M
55
3.5 yrs
V. Ravichandran
Vice Chairman
₹950K
62
7.8 yrs
Murugappan Murugappan
Executive Chairman
₹3M
63
1.3 yrs
B. V. R. Reddy
Non-Executive & Independent Director
₹1M
68
11.3 yrs
Prasad Chandran
Non-Executive & Independent Director
₹1M
66
5 yrs
Sumit Bose
Non-Executive & Independent Director
₹1M
64
3.1 yrs
Arunachalam Vellayan
₹17M
65
Muthiah Venkatachalam
Non-Executive Director
₹1M
60
12.3 yrs
Aruna Advani
Additional Women Independent Director
64
0.7 yrs
Nagarajan Ramamurthy
Independent Director
59
0.5 yrs
Who owns this company?
Recent Insider Trading
- Coromandel International insiders have only sold shares in the past 3 months.
Recent Insider Transactions
| Announced | Type | Name | Entity | Role | Start | End | Shares | Max Price (₹) | Value (₹) | |
|---|---|---|---|---|---|---|---|---|---|---|
| 04. Apr 19 | Sell | Aminul Islam | Individual | 25. Mar 19 | 25. Mar 19 | -1,608 | ₹481.89 | ₹-774,884 | ||
| 03. Apr 19 | Sell | Ripu Singh | Individual | 29. Mar 19 | 29. Mar 19 | -5,000 | ₹505.00 | ₹-2,525,000 | ||
| 28. Mar 19 | Buy | M M Venkatachalam Family Trust | Company | 25. Mar 19 | 25. Mar 19 | 2,818 | ₹480.10 | ₹1,352,922 | ||
| 28. Mar 19 | Buy | Lakshmi Venkatachalam Family Trust | Company | 25. Mar 19 | 25. Mar 19 | 65,101 | ₹480.10 | ₹31,254,987 | ||
| 28. Mar 19 | Buy | M M Murugappan Family Trust | Company | 26. Mar 19 | 26. Mar 19 | 3,300 | ₹482.35 | ₹1,591,755 | ||
| 28. Mar 19 | Sell | Srikanthan Srinivasan | Individual | 26. Mar 19 | 26. Mar 19 | -5,000 | ₹480.00 | ₹-2,400,000 | ||
| 28. Mar 19 | Sell | N. Shankar | Individual | 25. Mar 19 | 25. Mar 19 | -11,820 | ₹479.40 | ₹-5,666,566 | ||
| 28. Mar 19 | Sell | Meenakshi Murugappan | Individual | 26. Mar 19 | 26. Mar 19 | -3,300 | ₹482.35 | ₹-1,591,755 | ||
| 28. Mar 19 | Sell | Muthiah Venkatachalam | Individual | 25. Mar 19 | 25. Mar 19 | -65,101 | ₹480.10 | ₹-31,254,987 | ||
| 14. Mar 19 | Sell | C. Sitaram | Individual | 11. Mar 19 | 12. Mar 19 | -4,665 | ₹493.42 | ₹-2,294,543 | ||
| 14. Mar 19 | Sell | Ambadasu Rao | Individual | 12. Mar 19 | 12. Mar 19 | -3,000 | ₹501.20 | ₹-1,503,600 | ||
| 11. Mar 19 | Sell | T. Raghavan | Individual | 07. Mar 19 | 08. Mar 19 | -2,450 | ₹479.81 | ₹-1,161,497 | ||
| 11. Mar 19 | Sell | Ripu Singh | Individual | 07. Mar 19 | 08. Mar 19 | -7,500 | ₹480.00 | ₹-3,520,027 | ||
| 08. Mar 19 | Sell | T. Raghavan | Individual | 01. Feb 19 | 05. Mar 19 | -3,000 | ₹460.00 | ₹-1,372,550 | ||
| 04. Jan 19 | Buy | Subramanian Family Trust | Company | 31. Dec 18 | 31. Dec 18 | 65,102 | ₹450.25 | ₹29,312,175 | ||
| 04. Jan 19 | Buy | M/S. M M Muthiah Family Trust | Company | 31. Dec 18 | 31. Dec 18 | 443,252 | ₹450.25 | ₹199,574,207 | ||
| 04. Jan 19 | Buy | M M Veerappan Family Trust | Company | 31. Dec 18 | 31. Dec 18 | 378,150 | ₹450.25 | ₹170,262,032 | ||
| 04. Jan 19 | Sell | Meenakshi Murugappan | Individual | 31. Dec 18 | 31. Dec 18 | -378,150 | ₹450.25 | ₹-170,262,032 | ||
| 04. Jan 19 | Sell | Lakshmi Venkatachalam | Individual | 31. Dec 18 | 31. Dec 18 | -65,102 | ₹450.25 | ₹-29,312,175 | ||
| 04. Jan 19 | Sell | Muthiah Venkatachalam | Individual | 31. Dec 18 | 31. Dec 18 | -65,102 | ₹450.25 | ₹-29,312,175 | ||
| 28. Dec 18 | Sell | N. Shankar | Individual | 24. Dec 18 | 24. Dec 18 | -3,999 | ₹446.38 | ₹-1,785,056 | ||
| 24. Dec 18 | Sell | K. Muruganandham | Individual | 19. Dec 18 | 20. Dec 18 | -2,500 | ₹452.67 | ₹-1,126,613 | ||
| 20. Dec 18 | Sell | K. Muruganandham | Individual | 14. Dec 18 | 18. Dec 18 | -2,101 | ₹446.50 | ₹-924,720 | ||
| 07. Dec 18 | Sell | K. Muruganandham | Individual | 03. Dec 18 | 03. Dec 18 | -2,000 | ₹415.75 | ₹-831,500 | ||
| 04. Dec 18 | Sell | K. Muruganandham | Individual | 27. Nov 18 | 30. Nov 18 | -2,000 | ₹406.50 | ₹-804,264 | ||
| 01. Nov 18 | Sell | K. Muruganandham | Individual | 29. Oct 18 | 31. Oct 18 | -9,026 | ₹420.00 | ₹-3,700,534 | ||
| 31. Aug 18 | Sell | Amit Rastogi | Individual | 06. Aug 18 | 29. Aug 18 | -3,000 | ₹450.99 | ₹-1,311,009 | ||
| 03. Jul 18 | Sell | K. Muruganandham | Individual | 27. Jun 18 | 27. Jun 18 | -2,000 | ₹400.00 | ₹-800,000 | ||
| 29. Jun 18 | Sell | Amit Rastogi | Individual | 26. Jun 18 | 26. Jun 18 | -5,500 | ₹396.09 | ₹-2,178,500 | ||
| 24. May 18 | Sell | Amit Rastogi | Individual | 22. May 18 | 22. May 18 | -2,400 | ₹440.11 | ₹-1,056,269 | ||
Management checks
We assess Coromandel International's management by checking for:- Is the CEO's compensation unreasonable compared to market cap? (1 check)
- Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
- Is the average tenure of the management team less than 2 years? (1 check)
- Is the average tenure of the board of directors team less than 3 years? (1 check) Coromandel International has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.
Note: We use the top 6 management executives and board members in our calculations.
Note 2: Insider trading include any internal stakeholders and these transactions .
Full details on the Management part of the Simply Wall St company analysis model.
News
Simply Wall St News
Should Coromandel International Limited (NSE:COROMANDEL) Be Part Of Your Dividend Portfolio?
Is Coromandel International Limited (NSE:COROMANDEL) a good dividend stock? … While Coromandel International's 1.5% dividend yield is not the highest, we think its lengthy payment history is quite interesting. … There are a few simple ways to reduce the risks of buying Coromandel International for its dividend, and we'll go through these below.
Simply Wall St - – Full articleShould We Worry About Coromandel International Limited's (NSE:COROMANDEL) P/E Ratio?
To keep it practical, we'll show how Coromandel International Limited's (NSE:COROMANDEL) P/E ratio could help you assess the value on offer. … How Do I Calculate Coromandel International's Price To Earnings Ratio … Price to Earnings Ratio = Share Price ÷ Earnings per Share (EPS)
Simply Wall St - – Full articleWant To Invest In Coromandel International Limited (NSE:COROMANDEL)? Here's How It Performed Lately
Assessing Coromandel International Limited's (NSE:COROMANDEL) past track record of performance is a useful exercise for investors. … See our latest analysis for Coromandel International? … Furthermore, this one-year growth rate has been lower than its average earnings growth rate over the past 5 years of 17%, indicating the rate at which COROMANDEL is growing has slowed down
Simply Wall St - – Full articleCoromandel International Limited (NSE:COROMANDEL) Earns Among The Best Returns In Its Industry
In particular, we'll consider its Return On Capital Employed (ROCE), as that can give us insight into how profitably the company is able to employ capital in its business. … Return On Capital Employed (ROCE): What is it? … ROCE measures the amount of pre-tax profits a company can generate from the capital employed in its business.
Simply Wall St - – Full articleIs Coromandel International Limited (NSE:COROMANDEL) Overpaying Its CEO?
This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. … See our latest analysis for Coromandel International … How Does Sameer Goel's Compensation Compare With Similar Sized Companies?
Simply Wall St - – Full articleIs Coromandel International Limited (NSE:COROMANDEL) A Volatile Stock?
If you're interested in Coromandel International Limited (NSE:COROMANDEL), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your portfolio. … Beta can be a useful tool to understand how much a stock is influenced by market risk (volatility). … A stock with a beta below one is either less volatile than the market, or more volatile but not corellated with the overall market.
Simply Wall St - – Full articleCoromandel International Limited (NSE:COROMANDEL) Has Attractive Fundamentals
Building up an investment case requires looking at a stock holistically. … Today I've chosen to put the spotlight on Coromandel International Limited (NSE:COROMANDEL) due to its excellent fundamentals in more than one area. … COROMANDEL
Simply Wall St - – Full articleWho Has Been Selling Coromandel International Limited (NSE:COROMANDEL) Shares?
So shareholders might well want to know whether insiders have been buying or selling shares in Coromandel International Limited (NSE:COROMANDEL). … The Last 12 Months Of Insider Transactions At Coromandel International. … That means that an insider was selling shares at below the current price (₹456)
Simply Wall St - – Full articleA Look At The Intrinsic Value Of Coromandel International Limited (NSE:COROMANDEL)
In this article I am going to calculate the intrinsic value of Coromandel International Limited (NSE:COROMANDEL). … by projecting its future cash flows and then discounting them to today's value. … Discounted Cash Flows (DCF).
Simply Wall St - – Full articleWhat Kind Of Shareholders Own Coromandel International Limited (NSE:COROMANDEL)?
If you want to know who really controls Coromandel International Limited (NSE:COROMANDEL), then you'll have to look at the makeup of its share registry. … Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions as shareholders. … Companies that have been privatized tend to have low insider ownership.
Simply Wall St - – Full articleCompany Info
Description
Coromandel International Limited manufactures and trades in farm inputs in India. The company operates in two segments, Nutrient and Other Allied Business; and Crop Protection. It offers phosphatic fertilizers; crop protection products, including insecticides, fungicides, and herbicides; specialty nutrients, such as bentonite sulphur, water soluble and organic fertilizers, and micronutrients; and organic compost. The company also operates 800 stores under the Mana Gromor name in Andhra Pradesh, Telangana, and Karnataka, which offer farm inputs, as well as provides farm mechanization services. It offers its products under the Gromor, Godavari, and Double Horse brand names. Coromandel International Limited also exports its crop protection products to customers in Latin America, Africa, Europe, and Asia. The company was incorporated in 1961 and is based in Secunderabad, India. Coromandel International Limited is a subsidiary of E.I.D. Parry (India) Limited.
Details
| Name: | Coromandel International Limited |
| COROMANDEL | |
| Exchange: | NSEI |
| Founded: | 1961 |
| ₹128,668,145,660 | |
| 292,527,329 | |
| Website: | http://www.coromandel.biz |
| Address: |
Coromandel International Limited Coromandel House, 1-2-10, Sardar Patel Road, Secunderabad, Andhra Pradesh, 500003, India |
Listings
| Exchange Symbol | Ticker Symbol | Security | Exchange | Country | Currency | Listed on | |
|---|---|---|---|---|---|---|---|
| NSEI | COROMANDEL | Equity Shares | National Stock Exchange of India | IN | INR | 13. Jun 1995 | |
| BSE | 506395 | Equity Shares | Mumbai Stock Exchange | IN | INR | 13. Jun 1995 |
Number of employees
Current staff
Industry
| Fertilizers and Agricultural Chemicals | |
| Materials |
Company Analysis and Financial Data Status
| Area | Date (UTC time) |
|---|---|
| Company Analysis updated: | 2019/04/20 12:48 |
| End of day share price update: | 2019/04/18 00:00 |
| Last estimates confirmation: | 2019/04/18 |
| Last earnings filing: | 2019/01/21 |
| Last earnings reported: | 2018/12/31 |
| Last annual earnings reported: | 2018/03/31 |
All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
